Recent work by our group showed that CCAR2 plays a critical role in establishing active chromatin landscapes and superenhancers in colon cancer cells by regulating p300- and KMT2D-mediated epigenetic modifications of histone H319 (Fig. 2f). Here, CCAR2 is linked to malignant colon neoplasm.